BREAKINGUSDJPY and XAUUSD react as US carrier arrives in Middle East amid Iran tensions

Healthcare stocks face an uncertain outlook as political control of Congress shifts

Healthcare stocks face a period of uncertainty and potential legislative gridlock as Democrats prepare to assume control of Congress, prompting analysts to reassess sector strategies.

EQUITIESSTOCKSFXROLL
60-second read
  • Healthcare sector outlook remains uncertain due to expected legislative gridlock in Congress.
  • Pharmaceutical stocks are currently trading at higher valuations than technology shares for the first time in two decades.
  • The State Street Health Care Select ETF has risen approximately 32% since January 2025.
  • Analysts suggest focusing on individual subsectors, such as medical devices, rather than the industry as a whole.

Healthcare stocks face an uncertain outlook as political control of Congress shifts

Investors in the healthcare sector are bracing for a period of potential stagnation as the shifting political landscape in Congress suggests a high likelihood of legislative gridlock. With Democrats preparing to take control, market participants are weighing how this transition might influence regulatory environments and corporate performance over the coming years.

Key numbers at a glance

  • State Street Health Care Select ETF: +3% immediate jump following Election Day
  • State Street Health Care Select ETF performance: +32% since January 2025
  • Outperformance vs S&P 500: +9 percentage points

What happened

Following the recent election results, the healthcare sector has entered a phase of heightened uncertainty. Jared Holz, a healthcare sector specialist at Mizuho, indicated that the prospect of significant legislative progress over the next two years remains slim. Speaking on television, Holz noted that the current political environment makes it difficult to anticipate major policy shifts, which often serve as catalysts for stock movement.

Market performance for the sector has been mixed. The State Street Health Care Select ETF, a fund that tracks healthcare stocks, saw an immediate increase of +3% in the days following Election Day. However, the sector was subsequently caught in broader market volatility, ultimately finishing the week virtually flat. Despite this recent pause, the fund has demonstrated significant growth, rising +32% since January 2025, a performance that has outpaced the S&P 500 by nearly +9 percentage points.

What officials have said

Jared Holz has advised a cautious approach, suggesting that investors should avoid treating the healthcare sector as a single, uniform entity. He highlighted a notable shift in valuations, pointing out that pharmaceutical shares are currently trading more expensively than technology shares for the first time in two decades. Consequently, Holz has reduced his exposure to the pharmaceutical industry in favour of medical technology.

Looking further ahead, Holz suggested that a more definitive catalyst for the sector could emerge if a Democrat wins the presidency in 2028, provided that the party also maintains control of both the House and the Senate. Such a political alignment could potentially lead to the reversal of current administration strategies, which Holz believes could provide a boost to healthcare performance.

Background

Healthcare is often considered a defensive sector, meaning it typically provides stable returns regardless of the broader economic cycle. However, it is highly sensitive to government regulation, drug pricing policies, and changes in health insurance legislation. When Congress is divided, the legislative process often slows down, creating a "gridlock" that prevents major policy changes. For investors, this environment often shifts the focus from broad sector growth to specific subsectors, such as medical devices, which Holz noted are currently trading near multi-year lows.

What to watch next

  • Legislative developments regarding healthcare regulation in the new Congress.
  • Performance shifts between subsectors like pharmaceuticals and medical devices.
  • Broader market sentiment and its impact on defensive sectors like healthcare.

What it means for traders

Political shifts and changes in congressional control frequently trigger volatility across major indices and sector-specific exchange-traded funds (ETFs). Traders who monitor US equities often look for "sector rotation," where capital moves between defensive groups like healthcare and growth-oriented areas like technology. Legislative gridlock can influence valuations and broker sentiment, making it essential for traders to monitor regulatory announcements closely rather than assuming uniform movement across the entire healthcare industry.

Frequently asked questions

Why is pharmaceutical stock valuation a concern right now?

Pharmaceutical stocks are currently trading at higher price levels than technology stocks for the first time in 20 years. This unusual valuation gap has led some analysts to shift their focus toward other areas of the healthcare sector, such as medical technology.

How does political gridlock affect healthcare stocks?

Legislative gridlock occurs when different political parties control different branches of government, making it difficult to pass new laws. For healthcare, this often means that major regulatory changes or policy overhauls are unlikely, which can lead to uncertainty and a lack of clear direction for stock prices.

Risk warning: Trading foreign exchange and CFDs on margin carries a high level of risk and may not be suitable for all investors. Leverage can work against you. Content on FXROLL is for information and education only and is not investment advice. Prices and data may be delayed or contain errors.

Keep reading

More news →